ASO Author Reflections: Early-Stage Lobular Breast Cancer: Axillary Treatment In the Z0011 Era

Documenti analoghi

• Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers
  di: Mamtani, Anita, et al.
  Pubblicazione: (2019)
• ASO Author Reflections: Low-Volume Sentinel Node Disease after Neoadjuvant Chemotherapy Is Still an Indication for Axillary Dissection
  di: Moo, Tracy-Ann, et al.
  Pubblicazione: (2018)
• ASO Author Reflections: Biological Diversity of Histologic Subtypes
  di: Tadros, Audree B., et al.
  Pubblicazione: (2018)
• Does a positive axillary lymph node needle biopsy predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era?
  di: Pilewskie, Melissa, et al.
  Pubblicazione: (2015)
• ASO Author Reflections: Surgical Treatment for Male Breast Cancer in the Modern Era
  di: Sauder, Candice A. M.
  Pubblicazione: (2019)